Abstracts

Top-quality scientific content is what draws thousands of delegates to Europe’s largest urology meeting every year.

In the previous congress, more than 5,000 abstracts were submitted and reviewed by the EAU Scientific Congress Office.

You can submit your abstract via the online abstract submission system. The online abstract submission system is open from 1 July until 1 November 2017.

Important dates

1 July 2017 Abstract submission system open
1 November 2017 Deadline for abstract submission
November – December 2017 Abstract selection by reviewers and the EAU Scientific Congress Office members
19 December 2017 Outcome abstract selection available via the online abstract submission system. You will receive a notification by email.
16 February 2018 Abstracts (full bodies) are available in the EAU18 resource centre for EAU members only.
16 March 2018 Abstracts (full bodies) are available in the EAU18 resource centre.

Important notes

  • The deadline for abstract submission is 1 November 2017 (23.59:59).
  • Abstracts can only be submitted through the online abstract submission system.
  • Faxed, e-mailed or mailed abstracts will not be accepted.
  • Before submitting your abstract, carefully read the abstract submission rules.
  • Download abstract submission rules and regulations

Abstract topic list

Choose from the topics in the list below or download the list here.

1 Adrenals and retroperineal tumours
2 Kidney transplantation
3.1 Stones: Medical/research
3.2 Stones: ESWL
3.3 Stones: Open and percutaneous
3.4 Stones: Ureteroscopy
4 Upper tract stenting
5 Trauma and emergencies in urology
6 Infectious diseases
7.1.1 Prostate cancer: Basic research: Cell biology
7.1.2 Prostate cancer: Basic research: Novel biomarkers
7.1.3 Prostate cancer: Basic research: Novel therapies
7.2.1 Prostate cancer: Screening/diagnosis: PSA and novel biomarkers
7.2.2 Prostate cancer: Screening/diagnosis: Biopsies and imaging
7.3 Prostate cancer: Staging
7.4.1 Prostate cancer: Treatment: Active surveillance, focal, and ablative therapies
7.4.2 Prostate cancer: Treatment: Surgery
7.4.3 Prostate cancer: Treatment: Radiotherapy and brachytherapy
7.4.4 Prostate cancer: Treatment: Management of recurrence after local treatment
7.4.5 Prostate cancer: Treatment: Systemic
7.4.6 Prostate cancer: Treatment: Survivorship and supportive care
8.1 Urothelial tumours: Basic research
8.2 Urothelial tumours: Diagnosis
8.3 Urothelial tumours: Staging
8.4 Urothelial tumours: Management of non-muscle invasive bladder cancer
8.5.1 Urothelial tumours: Management of infiltrative/advanced bladder cancer: Surgical management
8.5.2 Urothelial tumours: Management of infiltrative/advanced bladder cancer: Non surgical management
8.6 Urothelial tumours: Upper urinary tract
9.1 Renal tumours: Basic research
9.2 Renal tumours: Diagnosis
9.3 Renal tumours: Non organ sparing surgical treatment
9.4 Renal tumours:  Nephron sparing approaches
9.5 Renal tumours: Systemic treatment
10.1 Functional LUTS, incontinence and neuro-urology: Basic science
10.2 Functional LUTS, incontinence and neuro-urology: Diagnosis
10.3 Functional LUTS, incontinence and neuro-urology: Treatment
11 BPH: Research, Diagnosis and treatment
12.1 Sexual dysfunction and andrology: Basic research
12.2 Sexual dysfunction and andrology: Diagnosis and treatment
13 Infertility
14 Reconstruction of the bladder and upper urinary tract
15 Urethral strictures, urethroplasty and  reconstruction of the external genitalia
16 Testis tumours
17 Penile cancer
18 Paediatric urology
19 Upper tract benign disease (not stones)
20 Enhanced recovery after urological surgery
21 Imaging in urology (non-prostate)
22 History of urology
23 New experimental technologies and techniques
24 Rare urogenital disease (incidence of less of 1 in 2000)
25 Geriatric urology
26 Education and training
27 Trials in progress